BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3390495)

  • 1. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY; Lowy MT; Locascio JJ
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
    Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of platelet MAO activity to characteristics of major depressive illness.
    Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE
    Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO activity in clinical subtypes of depression and DST suppression.
    Poirier MF; Lôo H; Mitrani N; Benkelfat C; Askienazy S; Le Fur G
    Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
    Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
    Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
    Wahlund B; Sääf J; Wetterberg L
    Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
    Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
    Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
    Maj M; Ariano MG; Arena F; Kemali D
    Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
    Ravindran AV; Bialik RJ; Lapierre YD
    J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
    Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity and evoked response as predictors of anxiety and depression derived from the content analysis of speech.
    Sabalesky DA; Demet EM; Chicz-Demet A; Gottschalk LA; Haier RJ
    J Psychiatr Res; 1990; 24(2):165-75. PubMed ID: 2213639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early morning awakening in unipolar depressives with higher levels of platelet MAO activity.
    Agren H; Oreland L
    Psychiatry Res; 1982 Oct; 7(2):245-54. PubMed ID: 6183704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B; Sääf J; Wetterberg L
    J Affect Disord; 1995 Oct; 35(1-2):75-87. PubMed ID: 8557890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet MAO activity and age at onset of depression in elderly depressed women.
    Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
    Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monoamine oxidase activity in elderly depressed outpatients.
    Schneider LS; Severson JA; Pollock V; Cowan RP; Sloane RB
    Biol Psychiatry; 1986 Dec; 21(14):1360-4. PubMed ID: 3790624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.